Uploaded October 2022 | Updated September 2026, 1 day ago
In this episode we are joined by Trevor Klee. Trevor is the founder of Highway Pharmaceuticals is a biotech startup creating drugs for autoimmune diseases. Right now, they're running a pilot trial of our drug in feline stomatitis.
Feline stomatitis is a serious autoimmune disease that affects 1 million cats per year in the US. The only treatment for it currently is a $1k+ surgery. By the end of the trial, we expect to have evidence that our drug can safely and effectively suppress the feline immune system. This positions our drug to become the only alternative to an expensive and traumatizing surgery.
Trevor is currently raising funds to cover the rest of the costs of the trial, as well as position us for our next milestones, which you can check out here: wefunder.com/highway.pharmaceuticals
In this episode we are joined by Trevor Klee. Trevor is the founder of Highway Pharmaceuticals is a biotech startup creating drugs for autoimmune diseases. Right now, they're running a pilot trial of our drug in feline stomatitis.
Feline stomatitis is a serious autoimmune disease that affects 1 million cats per year in the US. The only treatment for it currently is a $1k+ surgery. By the end of the trial, we expect to have evidence that our drug can safely and effectively suppress the feline immune system. This positions our drug to become the only alternative to an expensive and traumatizing surgery.
Trevor is currently raising funds to cover the rest of the costs of the trial, as well as position us for our next milestones, which you can check out here: wefunder.com/highway.pharmaceuticals
